TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT03044483

Intervention type: OTHER
Intervention: Measurement of sublingual microcirculatory parameters
Description: Measurement of the sublingual microcirculatory function using the CytoCam-IDF imaging device to establish the normal range for each age group noted.

Intervention type: OTHER
Intervention: Measurement of sublingual microcirculatory parameters
Description: Measurement of the sublingual microcirculatory function using the CytoCam-IDF imaging device to establish the normal range for each age group noted.
Study: NCT01726881

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Thermal stimulation
Description: Stimulation using a Thermal Sensory Analyzer:~2001, Maddock ltd., Israel.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Thermal stimulation
Description: Stimulation using a Thermal Sensory Analyzer:~2001, Maddock ltd., Israel.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Thermal stimulation
Description: Stimulation using a Thermal Sensory Analyzer:~2001, Maddock ltd., Israel.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Mechanical stimulation
Description: Stimulation using Semmes-Weinstein-Monofilament Touch Test Sensory Evaluators

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Mechanical stimulation
Description: Stimulation using Semmes-Weinstein-Monofilament Touch Test Sensory Evaluators

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Mechanical stimulation
Description: Stimulation using Semmes-Weinstein-Monofilament Touch Test Sensory Evaluators

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcutaneous Electrical Nerve Stimulator (TENS)
Description: A portable stimulator designed to Physical treatment of pain. TENS - Cedar rehab X2. Chattanooga group.USA.
Study: NCT00155389

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Helicobacter pylori eradication
Description: For subjects who received the first-line treatment, the costs included the initial 13C-UBT, one-week triple therapy (esomeprazole 40mg once daily, amoxicillin 1g twice daily, and clarithromycin 500mg twice daily), and the confirmatory 13C-UBT. For subjects in whom the initial treatment failed, the costs further included the re-treatment consisting of ten-day triple therapy (esomeprazole 40mg once daily, amoxicillin 1g twice daily, and levofloxacin 500mg once daily), and the confirmatory 13C-UBT.~The first round of study was between 2004 and 2005, the second round was between 2008 and 2009, and the third round was between 2012 and 2013.
Study: NCT05017922

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: transarterial chemoembolization combined with endoscopic therapy
Description: TACE: The tip of the catheter was advanced into tumor-feeding artery based on the tumor location and size. 5-Fu was injected. Then the chemolipiodolization was performed, using oxaliplatin, epirubicin and lipiodol. If stagnant flow did not realized, then injected pure lipiodol. If the tumor-feeding artery still cannot be completely embolized, several absorbable gelatin sponge particles would be injected. Endoscopic therapy: After the site of esophageal varices was identified by the gastroscopy, spiral ligation using the EVL device (COOK, MBL-6-F) was performed and ensure the varices were fully inhaled, 1-3 rubber bands were used totally. After EVL, water was sprayed to the ligation sites to check for bleeding. If gastric varices were found, EIS was performed using the 'sandwich method' of hypertonic glucose-tissue adhesive-normal saline. Make sure the needle entered the varieose vein before inject drugs, and repeated the injection if necessary.

Intervention type: PROCEDURE
Group type: OTHER
Intervention: transarterial chemoembolization combined with endoscopic therapy
Description: TACE: The tip of the catheter was advanced into tumor-feeding artery based on the tumor location and size. 5-Fu was injected. Then the chemolipiodolization was performed, using oxaliplatin, epirubicin and lipiodol. If stagnant flow did not realized, then injected pure lipiodol. If the tumor-feeding artery still cannot be completely embolized, several absorbable gelatin sponge particles would be injected. Endoscopic therapy: After the site of esophageal varices was identified by the gastroscopy, spiral ligation using the EVL device (COOK, MBL-6-F) was performed and ensure the varices were fully inhaled, 1-3 rubber bands were used totally. After EVL, water was sprayed to the ligation sites to check for bleeding. If gastric varices were found, EIS was performed using the 'sandwich method' of hypertonic glucose-tissue adhesive-normal saline. Make sure the needle entered the varieose vein before inject drugs, and repeated the injection if necessary.
Study: NCT02331381

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Magnetic resonance imaging
Study: NCT01829438

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Listening to fast music

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Listening to preferred music

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Listening to slow music
Study: NCT05011968

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Lettuce with not biofortification
Description: Lettuce without any biofortification was assigned to each participant belonging to the control group which ate 100gr every day for 10 days

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Lettuce biofortificated with Iodine
Description: Lettuce with Iodine biofortification was assigned to each participant belonging to the intervention group which ate 100gr every day for 10 days
Study: NCT01605929

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Retroclavicular Brachial Plexus Block and Catheter Insertion
Description: A Sonosite ultrasound machine will be used to visualize the nerve and needle simultaneously. A Braun 18 g 4 inch Touhy needle with markings will be inserted into the skin and advanced toward the nerve. Once the optimal location is determined under ultrasound visualization, the local anesthetic, mepivacaine, will be injected beside the nerves. The dose of drug will be mepivacaine 1.5%, 0.5 cc/kg (with a minimum 30 cc and maximum of 50 cc.) A Braun 20 g closed tip polyamide catheter will be inserted next to the nerve and left in place to allow for additional medication to be given postoperatively.
Study: NCT01615107

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: double balloonand oxytocin
Description: balloonand oxytocin

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: ballon and oxytocin
Description: double- balloon catheter device with concurrent oxytocin

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: double balloonand and oxytocin
Description: balloon catheter device with concurrent oxytocin
Study: NCT02133183

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Laboratory Biomarker Analysis
Description: Correlative studies

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Laboratory Biomarker Analysis
Description: Correlative studies

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pharmacological Study
Description: Correlative studies

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pharmacological Study
Description: Correlative studies

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sapanisertib
Description: Given PO

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sapanisertib
Description: Given PO
Study: NCT04790461

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pre-post test
Description: Adult Caregiver Quality of Life Questionnaire (AC-QoL) Perceived Stress Scale (PSS) The Stress Coping Styles Questionnaire (SCSQ)

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pre-post test
Description: Adult Caregiver Quality of Life Questionnaire (AC-QoL) Perceived Stress Scale (PSS) The Stress Coping Styles Questionnaire (SCSQ)

Intervention type: OTHER
Group type: OTHER
Intervention: Pre-post test
Description: Adult Caregiver Quality of Life Questionnaire (AC-QoL) Perceived Stress Scale (PSS) The Stress Coping Styles Questionnaire (SCSQ)

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: face-to-face training + PMR exercise
Description: 4 weeks Roy adaptation-based face-to-face training + PMR exercises to be taught, 4 weeks exercise counseling

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: mobile health education + PMR exercise
Description: To provide awareness and exercise with 8 weeks Roy adaptation model-based training and mobile application access with PMR exercise content

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: face-to-face and mobile health education + PMR exercise
Description: 4 weeks face-to-face training based on Roy adaptation model + teaching PMR exercises and 4 weeks based training on Roy adaptation model and mobile application access with PMR exercise content
Study: NCT01186692

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Melody® Transcatheter Pulmonary Valve
Description: Transcatheter Pulmonary Valve replacement Transcatheter valve implantation into a RVOT conduit in patients with complex congenital heart defects where the conduit has become dysfunctional and where the patient needs invasive intervention.
Study: NCT03751631

Intervention type: DRUG
Group type: OTHER
Intervention: Phenylephrine 2.5% ophthalmic solution (PE)
Description: Phenylephrine 2.5% ophthalmic solution administered with the Optejet microdose dispenser

Intervention type: DRUG
Group type: OTHER
Intervention: Phenylephrine 2.5% ophthalmic solution (PE)
Description: Phenylephrine 2.5% ophthalmic solution administered with the Optejet microdose dispenser
Study: NCT04238026

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Distal radial artery approach
Description: Use of distal radial artery approach in coronary angiography and angioplasty

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Distal radial artery approach
Description: Use of distal radial artery approach in coronary angiography and angioplasty
Study: NCT02937961

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Early SLED
Description: withing 6 to 12 hours

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Late SLED
Description: when absolute indications will meet
Study: NCT02508467

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fisogatinib (BLU-554)
Study: NCT03949166

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: food during labor and delivery
Description: The food that will be allowed during labor and delivery was approved by the anesthesia team. It includes - fruits, energy bars, yogurt,
Study: NCT03224182

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Qapzola
Description: Qapzola administered by the intravesical route.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Qapzole-matching placebo administered by the intravesical route.
Study: NCT02672254

Intervention type: RADIATION
Intervention: Samples with 2 treatments
Description: Study the concomitant effects between chemo- and radiotherapy by means of cellular techniques.
Study: NCT01176487

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: questionnaire administration

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: quality-of-life assessment

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: 3-dimensional conformal radiation therapy
Study: NCT02455700

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Interproximal Enamel Reduction
Description: removal of enamel between lower incisor teeth as part of orthodontic treatment plan to achieve the aims of treatment

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Interproximal Enamel Reduction
Description: removal of enamel between lower incisor teeth as part of orthodontic treatment plan to achieve the aims of treatment
Study: NCT01176487

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: palliative radiation therapy

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: whole-brain radiation therapy
Study: NCT01886456

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Laser trabeculoplasty

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Laser trabeculoplasty
Study: NCT02798068

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Solu-medrol or placebo administration
Description: patients will receive 500mg of methylprednisolone in 100ml NaCl 0,9% or placebo (100ml NaCl 0,9%) at anesthesia induction

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Solu-medrol or placebo administration
Description: patients will receive 500mg of methylprednisolone in 100ml NaCl 0,9% or placebo (100ml NaCl 0,9%) at anesthesia induction
Study: NCT00873951

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Intestinal and metabolic exploration
Description: Subjects are studied for 8h following the ingestion of a standard meal containing 15% of energy as protein. Intestinal, blood and urine are collected at regular intervals.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Intestinal and metabolic exploration
Description: Subjects are studied for 8h following the ingestion of a standard meal containing 15% of energy as protein. Intestinal, blood and urine are collected at regular intervals.
Study: NCT02120027

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ibodutant 10 mg
Description: Oral tablet, to be given once daily.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Oral tablet (identical in appearance and weight to ibodutant tablets) to be given once daily.
Study: NCT03192605

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Blueberry
Description: Blueberry - 150 grams wild blueberries (whole fruit)

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo - matched for calories and fiber
Study: NCT02328833

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Experimental strategies of guidelines implementation
Description: Experimental strategies of Depression Guidelines implementation in Primary Care Centers. The active process includes the establishment of local implementation teams, seminars, regular feedback and follow-up visits for four months.
Study: NCT00873951

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Intestinal and metabolic exploration
Description: Subjects are studied for 8h following the ingestion of a standard meal containing 15% of energy as protein. Intestinal, blood and urine are collected at regular intervals.

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: 15N-labelled intact casein
Description: standard mixed meal containing 15% of energy as 15N-labelled intact casein

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: 15N-labelled hydrolyzed casein
Description: standard mixed meal containing 15% of energy as 15N-labelled hydrolyzed casein

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: mixture of AA
Description: standard mixed meal containing 15% of energy as a mixture of AA mimicking the composition of casein but devoid in serine
Study: NCT02919475

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JTE-051
Description: Active drug tablets containing JTE-051

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JTE-051
Description: Active drug tablets containing JTE-051

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JTE-051
Description: Active drug tablets containing JTE-051

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JTE-051
Description: Active drug tablets containing JTE-051

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo tablets identical in appearance to the active drug tablets
Study: NCT00608205

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: cisplatin
Description: Given IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cisplatin
Description: Given IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: fluorouracil
Description: Given IV
Study: NCT02701985

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Matching-placebo capsules will be administered orally, 2 times a day with food.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RO5459072
Description: RO5459072 at a dose of 100 milligrams (as capsules) will be administered orally, 2 times a day with food.
Study: NCT01351298

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 0.05% xylometazoline hydrochloride with 1% lidocaine hydrochloride
Description: Decongestant with local anesthetic

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 0.05% xylometazoline hydrochloride
Description: Decongestant

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Isotonic normal saline
Description: Placebo
Study: NCT02529826

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Testicular Biopsy
Description: An open testicular biopsy will be performed by an attending urologist under general anesthesia.
Study: NCT00140504

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Medcheck message
Description: Participants selected at random will receive one email message asking them questions about their prescription which will be forwarded to their physician
Study: NCT00004070

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: IL-12

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: IL-12
Study: NCT00608205

Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: radiation therapy
Description: Patients undergo full-dose radiotherapy once or twice daily 5 days a week for up to 7 weeks

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: radiation therapy
Description: Patients undergo full-dose radiotherapy once or twice daily 5 days a week for up to 7 weeks
Study: NCT04527471

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ensifentrine Dose 1
Description: Study drug delivered twice daily via pMDI

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo pMDI
Description: Placebo delivered twice daily via pMDI
Study: NCT03378622

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Anchor
Description: Anchor technique for mesh attachment

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Suture
Description: Suture technique for mesh attachment
Study: NCT00287287

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lenalidomide
Description: Initial dose is 25 mg/day dose will be adjusted accordingly as needed. Dose range for the study is 5 to 25 mg/day
Study: NCT04872426

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise, insulin infusion
Description: Acute one-legged exercise, Insulin infusion 3 hours after one-legged exercise

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise, insulin infusion
Description: Acute one-legged exercise, Insulin infusion 3 hours after one-legged exercise

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise, insulin infusion
Description: Acute one-legged exercise, Insulin infusion 3 hours after one-legged exercise
Study: NCT01680185

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Insulin lispro, Humalog (Eli Lilly) in insulin pump
Description: all covered above

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Human insulin isophane, Humulin N (Eli Lilly)
Description: all covered above

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard of care
Description: all covered above
Study: NCT05582733

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cervical spine manipulation
Description: hot pack for 10 minutes will be applied followed by cervical manipulation (chin hold kaltenborn) once and then stretching

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cervical spine manipulation
Description: hot pack for 10 minutes will be applied followed by cervical manipulation (chin hold kaltenborn) once and then stretching

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: traction
Description: Hot pack will be applied followed by sustained pressure or MPR for 90 sec and then stretching.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: traction
Description: Hot pack will be applied followed by sustained pressure or MPR for 90 sec and then stretching.
Study: NCT02721797

Intervention type: PROCEDURE
Intervention: Orthopaedic & Gynaecology surgery
Description: Patients will have the surgery they require for their treatment. During surgery, debrided tissues will be retained for research. No treatment plans will be altered for this research.

Intervention type: PROCEDURE
Intervention: Orthopaedic & Gynaecology surgery
Description: Patients will have the surgery they require for their treatment. During surgery, debrided tissues will be retained for research. No treatment plans will be altered for this research.

Intervention type: PROCEDURE
Intervention: Orthopaedic & Gynaecology surgery
Description: Patients will have the surgery they require for their treatment. During surgery, debrided tissues will be retained for research. No treatment plans will be altered for this research.

Intervention type: PROCEDURE
Intervention: Orthopaedic & Gynaecology surgery
Description: Patients will have the surgery they require for their treatment. During surgery, debrided tissues will be retained for research. No treatment plans will be altered for this research.

Intervention type: PROCEDURE
Intervention: Orthopaedic & Gynaecology surgery
Description: Patients will have the surgery they require for their treatment. During surgery, debrided tissues will be retained for research. No treatment plans will be altered for this research.
Study: NCT02342444

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Enoxaparin Sodium Injection 30 mg BID

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Enoxaparin Sodium Injection 40 mg QD
Study: NCT03840746

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Tomato, onion and lovage soup (TOL)
Description: Soup

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: TOL soup with inulin
Description: Soup
Study: NCT02303561

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CHAMP
Description: Families assigned to this arm will receive tailored asthma education and behavioral skills focused on improving asthma and weight management.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Health education
Description: Families assigned to this arm will receive tailored asthma education and general health education on a variety of topics.
Study: NCT05433428

Intervention type: DRUG
Group type: OTHER
Intervention: Lubricant Eye Drops
Description: Prolonged use of lubricant eye drops pre and post-op.

Intervention type: DRUG
Group type: OTHER
Intervention: Preservative Free
Description: Preservative free eye drops

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Preservative
Description: Eyedrops with preservatives

Intervention type: DRUG
Group type: OTHER
Intervention: Preservative
Description: Eyedrops with preservatives